Open an Account
☰
Open an Account
✖

US stocks 2021 year in review: “Big tech” stocks extend their run of dominance

Article By: ,  Head of Market Research
December 29, 2021 9:29 AM

With just a few trading days left in 2021 and volatility likely to be subdued, it’s a great time to review what worked and what didn’t over the past year.

Looking at US stocks, there’s a strong argument that just about everything “worked.” As the chart below shows, every single major sector rose this year, led by energy and real estate, and even the lagging consumer staples, utilities and communication services stocks rose by nearly 20% on (a capitalization-weighted) average:

Source: Stockcharts.com

From a sector rotation perspective, strong performance by energy, technology, financials, and discretionary stocks historically suggests that we’re in a mid- to late- bull market cycle; as we flip the calendars to the 2022, traders should be wary if we start to see traditionally defensive sectors like utilities, consumers stapes, and health care start to outperform as a potential signal that the bull market may be peaking and a bear market may be around the corner.

Drilling down to an individual stock level, these were the top 10 performers in the S&P 500 and their sectors this year:

  1. Devon Energy (Energy) +199%
  2. Marathon Oil (Energy) +151%
  3. Fortinet (Technology) +146%
  4. Signature Bank (Financials) +142%
  5. Ford Motor (Discretionary) +137%
  6. NVIDIA (Technology) +132%
  7. Diamondback Energy (Energy) +132%
  8. Moderna (Health Care) +131%
  9. Bath & Body Works (Discretionary) +130%
  10. Nucor (Materials) +118%

And, perhaps more importantly, these 10 stocks were the biggest contributors to the S&P 500’s impressive nearly 30% gain in 2021:

  1. Microsoft (Technology) +55%
  2. Apple (Technology) +36%
  3. NVIDIA (Technology) +132%
  4. Alphabet (Communication Services) +67%
  5. Tesla (Discretionary) +27%
  6. Meta Platforms / Facebook (Communication Services) +27%
  7. Home Depot (Discretionary) +56%
  8. UnitedHealth Group (Health Care) +45%
  9. Pfizer (Health Care) +64%
  10. Berkshire Hathaway (Financials) +29%

Once again, the megacap technology stocks drove most of the gains in the overall indices, leading to an even heavier weighting in these names heading into 2022. For more on the outlook for these tech behemoths, see my colleague Josh Warner’s report “Big Tech stocks: What will they face in 2022?” as part of our full 2022 Market Outlook guide.

How to trade with FOREX.com

Follow these easy steps to start trading with FOREX.com today:

  1. Open a Forex.com account, or log-in if you’re already a customer.
  2. Search for the market you want to trade in our award-winning platform.
  3. Choose your position and size, and your stop and limit levels.
  4. Place the trade.

The information on this web site is not targeted at the general public of any particular country. It is not intended for distribution to residents in any country where such distribution or use would contravene any local law or regulatory requirement. The information and opinions in this report are for general information use only and are not intended as an offer or solicitation with respect to the purchase or sale of any currency or CFD contract. All opinions and information contained in this report are subject to change without notice. This report has been prepared without regard to the specific investment objectives, financial situation and needs of any particular recipient. Any references to historical price movements or levels is informational based on our analysis and we do not represent or warranty that any such movements or levels are likely to reoccur in the future. While the information contained herein was obtained from sources believed to be reliable, author does not guarantee its accuracy or completeness, nor does author assume any liability for any direct, indirect or consequential loss that may result from the reliance by any person upon any such information or opinions.

Futures, Options on Futures, Foreign Exchange and other leveraged products involves significant risk of loss and is not suitable for all investors. Losses can exceed your deposits. Increasing leverage increases risk. Spot Gold and Silver contracts are not subject to regulation under the U.S. Commodity Exchange Act. Contracts for Difference (CFDs) are not available for US residents. Before deciding to trade forex, commodity futures, or digital assets, you should carefully consider your financial objectives, level of experience and risk appetite. Any opinions, news, research, analyses, prices or other information contained herein is intended as general information about the subject matter covered and is provided with the understanding that we do not provide any investment, legal, or tax advice. You should consult with appropriate counsel or other advisors on all investment, legal, or tax matters. References to FOREX.com or GAIN Capital refer to StoneX Group Inc. and its subsidiaries. Please read Characteristics and Risks of Standardized Options.

Please note that foreign exchange and other leveraged trading involves significant risk of loss. It is not suitable for all investors and you should make sure you understand the risks involved, seeking independent advice if necessary.

Contracts for Difference (CFDs) are not available to US residents.

FOREX.com is a trading name of GAIN Capital - FOREX.com Canada Limited, 30 Independence Blvd, Suite 300 (3rd floor), Warren, NJ 07059, USA is a member of the Canadian Investment Regulatory Organization and Member of the Canadian Investor Protection Fund. GAIN Capital – FOREX.com Canada Limited is a wholly-owned subsidiary of Stonex Group Inc.

Complaints are taken very seriously at FOREX.com. You can view our complaints procedure here.

Know your advisor

© FOREX.COM 2025